Cutler Group’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20
Closed -$161 3885
2022
Q4
$0 Sell
20
-320
-94% -$5.9K ﹤0.01% 4463
2022
Q3
$7K Sell
340
-160
-32% -$4.86K ﹤0.01% 3362
2022
Q2
$17K Buy
+500
New +$40.6K ﹤0.01% 2789
2022
Q1
Sell
-1,083
Closed -$64.9K 5374
2021
Q4
$55K Buy
1,083
+109
+11% +$6.97K ﹤0.01% 2323
2021
Q3
$68K Buy
974
+150
+18% +$12.1K ﹤0.01% 2241
2021
Q2
$83K Sell
824
-1,945
-70% -$197K ﹤0.01% 2036
2021
Q1
$279K Buy
+2,769
New +$284K 0.01% 1057

Other funds holding CELU

Cutler Group's CELU Position: Q1 2023 in Review

Cutler Group sold out of Celularity (CELU) in Q1 2023, closing a stake of 20 shares — an estimated $161 sold.

Cutler Group first reported a position in CELU in Q1 2021 and held it in 7 quarters. The position peaked at $279K in Q1 2021. 61 funds tracked by Wall St. Rank hold CELU as of Q1 2023.

  • Cutler Group reported no remaining Celularity position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 20 Celularity shares in Q1 2023, an estimated $161.
  • Cutler Group first reported a position in Celularity in Q1 2021 and held it in 7 quarters.
  • Cutler Group's Celularity position peaked at $279K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Celularity as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.